The doxorubicin market is projected to reach US$ 1,983.40 million by 2028 from US$ 1,390.64 million in 2022. It is expected to register a CAGR of 6.1% from 2022 to 2028.
Doxorubicin belongs to the anthracycline family and is widely used to treat malignancies, such as breast, lung, multiple myeloma, ovarian, kidney, liver, sarcoma, and others. The product is used in patients with cancer whose disease has progressed or recurred after chemotherapy.
The report offers insights and in-depth analysis of the global doxorubicin market, emphasizing various parameters, such as market trends, technological advancements, and market dynamics. It also provides the competitive landscape analysis of leading market players and the impact of the COVID-19 pandemic on the market across all major regions.
The COVID-19 pandemic disrupted the socioeconomic conditions of various countries worldwide. The cost of overall healthcare is surging significantly in North America. The US health system incurred a direct cost of US$ 5.3 billion in 2020. The healthcare system contributed US$ 60 billion in addition to the overall annual costs of the country in 2020. Over 40% of the population in North America canceled their appointments in 2020, and 13% reported that they needed care but did not either schedule or receive care. The COVID-19 pandemic altered economic conditions and social behaviors in North American countries. Containment measures enacted by governments to mitigate the spread of disease changed the US healthcare service delivery pattern. According to the Department of Emergency Medicine, in many cities across the country, emergency department (ED) visits decreased by ~40% in 2020. Moreover, outpatient appointments and elective treatments were postponed or replaced by telemedicine practices.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Doxorubicin Market: Strategic Insights
Market Size Value in US$ 1,390.64 Million in 2022 Market Size Value by US$ 1,983.40 Million by 2028 Growth rate CAGR of 6.1% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2022
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Doxorubicin Market: Strategic Insights
| Market Size Value in | US$ 1,390.64 Million in 2022 |
| Market Size Value by | US$ 1,983.40 Million by 2028 |
| Growth rate | CAGR of 6.1% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2022 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
In November 2021, Pfizer Inc. announced the investigational COVID-19 oral antiviral candidate, PAXLOVID. Based on an interim analysis of the Phase 2/3 Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients (EPIC-HR), which is a randomized, double-blind study of non-hospitalized adult COVID-19 patients who were at a high risk of progressing to severe illness, the PAXLOVID vaccine reportedly reduced hospitalization and death. There were supply constraints related to vaccine production in the initial months of 2021. However, setting up new plants and promoting technological shifts are the strategies that support the production of booster doses in the US and Canada, along with their administration plans.
Furthermore, the chaotic situation was created in the healthcare industry across the countries, leading to a reduced number of consultations and a smaller number of cancer cases diagnosed. For instance, international efforts suggest that the diagnoses of cancers were reduced by 40% between March 9, 2020, and May 17, 2020, compared to diagnoses averaged over the same period in 2018 and 2019. In its disruption of clinical trials and drug supply to patients, the COVID-19 pandemic has impacted the most crucial areas of the global doxorubicin market.
Based on region, the global doxorubicin market is segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America.
Lucrative Regions for Global Doxorubicin Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Prevalence of Cancer Drives Global Doxorubicin Market
Increasing Prevalence of Cancer Drives Global Doxorubicin Market
Cancer is a leading cause of death globally. According to the World Health Organization (WHO), cancer was the first leading cause of death in people below 70 years in 183 countries and the fourth major cause of death among the population of all ages in 123 countries worldwide in 2019. In addition, as per the data published by the WHO in March 2021, different cancer types will have caused ~10 million deaths in 2020. The increasing prevalence of cancer has burdened healthcare systems worldwide, bolstering the demand for chemotherapy. Doxorubicin is one of the primary drugs used as first-line treatment in chemotherapy. The drug is used to induce regression in disseminated neoplastic diseases like breast, ovarian, transitional cell bladder, thyroid, gastric, acute lymphoblastic leukemia, acute myeloblastic leukemia, Wilms' tumor, neuroblastoma, soft tissue and bone sarcomas, Hodgkin's disease, malignant lymphoma, and bronchogenic carcinomas, in which the small cell histologic type. The drug is also recommended as adjuvant therapy in women who have had primary breast cancer removed and have axillary lymph node involvement.
According to Cancer Statistics, 2022, published in the American Cancer Society’s journal, data from 2015 to 2019 indicated a 0.5% annual increase in female breast cancer. At the same time, the incidence of prostate cancer remained stable. Thus, the increasing number of cancer patients worldwide is projected to drive global doxorubicin market growth.
Drug Formulation-based Insights
Based on drug formulation, the global doxorubicin market is bifurcated into lyophilized powder and doxorubicin injection. In 2022, the lyophilized powder segment accounted for a greater market share. The market position of this segment is due to the increasing prevalence of cancer, storage stability, and rising preference for chemotherapy.
Application-based Insights
Based on application, the global doxorubicin market is segmented into lung cancer, sarcoma, breast cancer, multiple myeloma, ovarian cancer, kidney cancer, leukemia, liver cancer, and others. The breast cancer segment is likely to dominate the market in 2022.
Distribution Channel-based Insights
Based on the distribution channel, the global doxorubicin market has been categorized into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment is expected to hold the largest market share in 2022.
Global Doxorubicin Market, by Distribution Channel– 2022 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Players in the global doxorubicin market adopt organic strategies, such as product launch and expansion, to increase their footprint and product portfolio worldwide.
By Geography, North America is further segmented into the US, Canada, and Mexico. Europe is bifurcated into France, Germany, Italy, the UK, Spain, and the Rest of Europe. APAC is divided into China, India, South Korea, Japan, Australia, and the Rest of APAC. Middle East and Africa is segmented into South Africa, Saudi Arabia, UAE, and the Rest of MEA. South and Central Ameirca is segmented into Brazil, Argentina, and the Rest of SCAM.
Some of the major players contributing in the doxorubicin market are Accord Healthcare, Cipla, Inc, Dr. Reddy, Cadila Pharmaceuticals, Meiji Seika Pharma Co, Janseen Pharmaceuticals (Johnson and Johnson Services, Inc.), Novartis AG, Pfizer, Inc., Sun Pharmaceutical Industries Ltd, Baxter International Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Drug Formulation, Application, and Distribution Channel
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Doxorubicin belongs to the anthracycline family and is widely used for the treatment of malignancies such as breast, lung, multiple myeloma, ovarian, kidney, liver, sarcoma, and others. The product is used in patients with cancer whose disease has progressed or recurred after chemotherapy.
Increasing prevalence of cancer and increasing preference of chemotherapy is one of the most significant factors responsible for the overall market growth.
Based on drug formulation, lyophilized powder dominated the market by accounting largest share in 2022 and is expected to continue to do so till the forecast period.
The breast cancer segment dominated the global doxorubicin market and accounted for the largest revenue of US $316.32 million in 2022.
Accord Healthcare, Cipla Inc., Dr. Reddy’s Laboratories, Meiji Holdings Co., Ltd., Janssen Pharmaceuticals (Johnson and Johnson Services, Inc.), Novartis AG, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Baxter International Inc., Zydus Cadila are among the leading companies operating in the global doxorubicin market
Global doxorubicin market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for doxorubicin market. The US is estimated to hold the largest share in the doxorubicin market during the forecast period. The presence of top players and favorable regulations related to product approvals coupled with commercializing new products are the contributing factors for the regional growth. Additionally, the increasing number of technological advancements is the key factor responsible for the Asia-Pacific regional growth for doxorubicin accounting fastest growth of the region during the coming years.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Doxorubicin Market – By Drug Formulation
1.3.2 Global Doxorubicin Market – By Application
1.3.3 Global Doxorubicin Market – By Distribution Channel
1.3.4 Global Doxorubicin Market – By Geography
2. Doxorubicin market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Doxorubicin Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East & Africa – PEST Analysis
4.2.5 South & Central America – PEST Analysis
4.3 Expert Opinion
5. Doxorubicin Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Cancer
5.1.2 Increasing Preference for Chemotherapy
5.2 Market Restraints
5.2.1 Potential Side-effects Associated with Doxorubicin
5.3 Market Opportunities
5.3.1 Increasing Government Funding, Guidance, and Technical Assistance for Cancer Prevention
5.4 Future Trends
5.4.1 Increasing Approval of Generic Products
5.5 Impact Analysis
6. Doxorubicin Market– Global Analysis
6.1 Global Doxorubicin Market Revenue Forecast and Analysis
6.1.1 Global Doxorubicin Market Revenue Forecast and Analysis
6.1.2 Global Doxorubicin Market– Market Potential Analysis, By Region
6.2 Market Share Analysis
6.2.1 Company Analysis
6.2.2 Growth Strategy Analysis
6.2.3 Market Positioning of Key Players in Doxorubicin Market
6.2.3.1 Janssen Pharmaceuticals (Johnson and Johnson Services, Inc.)
6.2.3.2 Pfizer Inc.
7. Global Doxorubicin Market Revenue and Forecast to 2028 – by Drug Formulation
7.1 Overview
7.2 Global Doxorubicin Market Share, By Drug Formulation 2022 & 2028 (%)
7.3 Lyophilized Powder
7.3.1 Overview
7.3.2 Lyophilized Powder: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
7.4 Doxorubicin Injection
7.4.1.1 Overview
7.4.2 Doxorubicin Injection: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8. Global Doxorubicin Market Revenue and Forecast to 2028 – by Application
8.1 Overview
8.2 Global Doxorubicin Market Share, By Application 2022 & 2028 (%)
8.3 Breast Cancer
8.3.1.1 Overview
8.3.2 Breast Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.4 Kidney Cancer
8.4.1.1 Overview
8.4.2 Kidney Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.5 Liver Cancer
8.5.1.1 Overview
8.5.2 Liver Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.6 Sarcoma
8.6.1.1 Overview
8.6.2 Sarcoma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.7 Ovarian Cancer
8.7.1.1 Overview
8.7.2 Ovarian Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.8 Lung Cancer
8.8.1 Overview
8.8.2 Lung Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.9 Leukemia
8.9.1.1 Overview
8.9.2 Leukemia: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.10 Multiple Myeloma
8.10.1.1 Overview
8.10.2 Multiple Myeloma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.11 Others
8.11.1.1 Overview
8.11.2 Others: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
9. Global Doxorubicin Market Revenue and Forecast to 2028 – by Disribution Channel
9.1 Overview
9.2 Global Doxorubicin Market Share, By Disribution Channel 2022 & 2028 (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
9.4 Retail Pharmacy
9.4.1.1 Overview
9.4.2 Retail Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
9.5 Online Pharmacy
9.5.1.1 Overview
9.5.2 Online Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
10. Global Doxorubicin Market Revenue and Forecast to 2028– by Geography
10.1 North America: Doxorubicin Market Revenue and Forecasts To 2028
10.1.1 Overview
10.1.2 North America: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)
10.1.4 North America: Doxorubicin Market, by Application, 2019–2028 (US$ Million)
10.1.5 North America: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)
10.1.6 North America: Doxorubicin Market, by Country, 2022 & 2028 (%)
10.1.6.1 US: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.3 US: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)
10.1.6.1.4 US: Doxorubicin Market, by Application, 2019–2028 (US$ Million)
10.1.6.1.5 US: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)
10.1.6.2 Canada: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.3 Canada: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)
10.1.6.2.4 Canada: Doxorubicin Market, by Application, 2019–2028 (US$ Million)
10.1.6.2.5 Canada: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)
10.1.6.3 Mexico: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.3 Mexico: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)
10.1.6.3.4 Mexico: Doxorubicin Market, by Application, 2019–2028 (US$ Million)
10.1.6.3.5 Mexico: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)
10.2 Europe Doxorubicin Market, Revenue and Forecast to 2028
10.2.1 Overview
10.2.2 Europe Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)
10.2.3 Europe Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)
10.2.4 Europe Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)
10.2.5 Europe Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)
10.2.6 Europe Doxorubicin Market, Revenue and Forecast to 2028, by Country (%)
10.2.6.1 UK Doxorubicin Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.6.1.1 UK Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)
10.2.6.1.2 UK Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)
10.2.6.1.3 UK Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)
10.2.6.1.4 UK Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)
10.2.6.2 Germany Doxorubicin Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.2.1 Germany Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)
10.2.6.2.2 Germany Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)
10.2.6.2.3 Germany Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)
10.2.6.2.4 Germany Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)
10.2.6.3 France Doxorubicin Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.3.1 France Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)
10.2.6.3.2 France Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)
10.2.6.3.3 France Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)
10.2.6.3.4 France Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)
10.2.6.4 Italy Doxorubicin Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.4.1 Italy Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)
10.2.6.4.2 Italy Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)
10.2.6.4.3 Italy Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)
10.2.6.4.4 Italy Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)
10.2.6.5 Spain Doxorubicin Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.5.1 Spain Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)
10.2.6.5.2 Spain Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)
10.2.6.5.3 Spain Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)
10.2.6.5.4 Spain Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)
10.2.6.6 Rest of Europe Doxorubicin Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.6.1 Rest of Europe Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)
10.2.6.6.2 Rest of Europe Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)
10.2.6.6.3 Rest of Europe Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)
10.2.6.6.4 Rest of Europe Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)
10.3 Asia Pacific: Doxorubicin Market
10.3.1 Overview
10.3.2 Asia Pacific: Doxorubicin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific: Doxorubicin Market, By Drug Formulation, 2019–2028 (US$ Million)
10.3.4 Asia Pacific: Doxorubicin Market, by Application, 2019–2028 (US$ Million)
10.3.5 Asia Pacific: Doxorubicin Market, By Distribution Channel, 2019–2028 (US$ Million)
10.3.6 Asia Pacific: Doxorubicin Market, by Country, 2022 & 2028 (%)
10.3.6.1 China: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.1 China: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.2 China: Doxorubicin Market, By Drug Formulation, 2019–2028 (US$ Million)
10.3.6.1.3 China: Doxorubicin Market, by Application, 2019–2028 (US$ Million)
10.3.6.1.4 China: Doxorubicin Market, By Distribution Channel, 2019–2028 (US$ Million)
10.3.6.2 Japan: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.1 Japan: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.2 Japan: Doxorubicin Market, By Drug Formulation, 2019–2028 (US$ Million)
10.3.6.2.3 Japan: Doxorubicin Market, By Application, 2019–2028 (US$ Million)
10.3.6.2.4 Japan: Doxorubicin Market, By Distribution Channel, 2019–2028 (US$ Million)
10.3.6.3 India: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.1 India: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.2 India: Doxorubicin Market, By Drug Formulation, 2019–2028 (US$ Million)
10.3.6.3.3 India: Doxorubicin Market, By Application, 2019–2028 (US$ Million)
10.3.6.3.4 India: Doxorubicin Market, By Distribution Channel, 2019–2028 (US$ Million)
10.3.6.4 South Korea: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.1 South Korea: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.2 South Korea: Doxorubicin Market, By Drug Formulation, 2019–2028 (US$ Million)
10.3.6.4.3 South Korea: Doxorubicin Market, By Application, 2019–2028 (US$ Million)
10.3.6.4.4 South Korea: Doxorubicin Market, By Distribution Channel, 2019–2028 (US$ Million)
10.3.6.5 Australia: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.1 Australia: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.2 Australia: Doxorubicin Market, By Drug Formulation, 2019–2028 (US$ Million)
10.3.6.5.3 Australia: Doxorubicin Market, By Application, 20192028 (US$ Million)
10.3.6.5.4 Australia: Doxorubicin Market, By Distribution Channel, 2019–2028 (US$ Million)
10.3.6.6 Rest of Asia Pacific: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Rest of Asia Pacific: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.2 Rest of Asia Pacific: Doxorubicin Market, By Drug Formulation, 2019–2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Doxorubicin Market, By Application, 2019–2028 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Doxorubicin Market, By Distribution Channel, 2019–2028 (US$ Million)
10.4 South and Central America: Doxorubicin Market Revenue and Forecasts To 2028
10.4.1 Overview
10.4.2 South and Central America: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.4.3 South and Central America: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)
10.4.4 South and Central America: Doxorubicin Market, by Application, 2019–2028 (US$ Million)
10.4.5 South and Central America: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)
10.4.6 South and Central America: Doxorubicin Market, by Country, 2022 & 2028 (%)
10.4.6.1 Brazil: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.1 Overview
10.4.6.1.2 Brazil: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.3 Brazil: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)
10.4.6.1.4 Brazil: Doxorubicin Market, by Application, 2019–2028 (US$ Million)
10.4.6.1.5 Brazil: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)
10.4.6.2 Argentina: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.1 Overview
10.4.6.2.2 Argentina: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.3 Argentina: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)
10.4.6.2.4 Argentina: Doxorubicin Market, by Application, 2019–2028 (US$ Million)
10.4.6.2.5 Argentina: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)
10.4.6.3 Rest of South and Central America: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 Overview
10.4.6.3.2 Rest of South and Central America: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.3 Rest of South and Central America: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)
10.4.6.3.4 Rest of South and Central America: Doxorubicin Market, by Application, 2019–2028 (US$ Million)
10.4.6.3.5 Rest of South and Central America: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)
10.5 Middle East & Africa Doxorubicin Market
10.5.1 Overview
10.5.2 Middle East & Africa Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
10.5.3 Middle East & Africa: Doxorubicin Market, Revenue and Forecasts to 2028, By Drug Formulation (US$ Million)
10.5.3.1 Middle East & Africa: Doxorubicin Market, Revenue and Forecasts to 2028, By Application (US$ Million)
10.5.4 Middle East & Africa: Doxorubicin Market-Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
10.5.5 Middle East & Africa Doxorubicin Market Revenue and Forecast to 2028, by Country (%)
10.5.5.1 Saudi Arabia: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
10.5.5.1.1 Saudi Arabia: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
10.5.5.1.2 Saudi Arabia: Doxorubicin Market, Revenue and Forecasts to 2028, By Drug Formulation (US$ Million)
10.5.5.1.3 Saudi Arabia: Doxorubicin Market, Revenue and Forecasts to 2028, By Application (US$ Million)
10.5.5.1.4 Saudi Arabia: Doxorubicin Market-Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
10.5.5.2 South Africa: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
10.5.5.2.1 South Africa Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
10.5.5.2.2 South Africa: Doxorubicin Market, Revenue and Forecasts to 2028, By Drug Formulation (US$ Million)
10.5.5.3 South Africa: Doxorubicin Market, Revenue and Forecasts to 2028, By Application (US$ Million)
10.5.5.3.1 South Africa: Doxorubicin Market-Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
10.5.5.4 UAE: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
10.5.5.4.1 UAE: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
10.5.5.4.2 UAE : Doxorubicin Market, Revenue and Forecasts to 2028, By Drug Formulation (US$ Million)
10.5.5.4.3 UAE : Doxorubicin Market, Revenue and Forecasts to 2028, By Application (US$ Million)
10.5.5.4.4 UAE : Doxorubicin Market-Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
10.5.5.5 Rest of Middle East & Africa: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
10.5.5.5.1 Rest of Middle East & Africa: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
10.5.5.5.2 Rest Of Middle East & Africa: Doxorubicin Market, Revenue and Forecasts to 2028, By Drug Formulation (US$ Million)
10.5.5.5.3 Rest Of Middle East & Africa: Doxorubicin Market, Revenue and Forecasts to 2028, By Application (US$ Million)
10.5.5.5.4 Rest Of Middle East & Africa: Doxorubicin Market-Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
11. Impact of COVID-19 Pandemic on Geographic Regions
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment Of COVID-19 Pandemic
11.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
11.5 South And Central America: Impact Assessment Of COVID-19 Pandemic
12. Doxorubicin Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Accord Healthcare
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Cipla Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Dr. Reddy's Laboratories
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Meiji Holdings Co., Ltd.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Novartis AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Pfizer Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Sun Pharmaceutical Industries Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Baxter International Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Zydus Cadila
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America: Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Doxorubicin Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 4. US Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada: Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico: Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico: Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 13. Europe Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)
Table 14. Europe Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)
Table 15. Europe Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)
Table 16. UK Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)
Table 17. UK Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)
Table 18. UK Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)
Table 19. Germany Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)
Table 20. Germany Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)
Table 21. Germany Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)
Table 22. France Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)
Table 23. France Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)
Table 24. France Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)
Table 25. Italy Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)
Table 26. Italy Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)
Table 27. Italy Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)
Table 28. Spain Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)
Table 29. Spain Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)
Table 30. Spain Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)
Table 31. Rest of Europe Doxorubicin Market Revenue and Forecast to 2028, by Drug Formulation (US$ Mn)
Table 32. Rest of Europe Doxorubicin Market, Revenue and Forecast to 2028, by Application (US$ Mn)
Table 33. Rest of Europe Doxorubicin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Mn)
Table 34. Asia Pacific: Doxorubicin Market, By Drug Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 35. Asia Pacific: Doxorubicin Market, by Application – Revenue and forecast to 2028 (US$ Million)
Table 36. Asia Pacific: Doxorubicin Market, By Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 37. China: Doxorubicin Market, By Drug Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 38. China: Doxorubicin Market, by Application – Revenue and forecast to 2028 (US$ Million)
Table 39. China: Doxorubicin Market, By Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 40. Japan: Doxorubicin Market, By Drug Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 41. Japan: Doxorubicin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 42. Japan: Doxorubicin Market, By Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 43. Incidence, Mortality, and Prevalence by Cancer Site (2020)
Table 44. India: Doxorubicin Market, By Drug Formulation– Revenue and Forecast to 2028 (US$ Million)
Table 45. India: Doxorubicin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 46. India: Doxorubicin Market, By Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 47. South Korea: Doxorubicin Market, By Drug Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 48. South Korea: Doxorubicin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 49. South Korea: Doxorubicin Market, By Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 50. Australia: Doxorubicin Market, By Drug Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 51. Australia: Doxorubicin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 52. Australia: Doxorubicin Market, By Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Asia Pacific: Doxorubicin Market, By Drug Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Asia Pacific: Doxorubicin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 55. Rest of Asia Pacific: Doxorubicin Market, By Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 56. South and Central America Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 57. South and Central America: Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 58. South and Central America Doxorubicin Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 59. Brazil: Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 60. Brazil: Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 61. Brazil Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 62. Argentina Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 63. US Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 64. US Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 65. Rest of South and Central America: Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 66. Rest of South and Central America: Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 67. Rest of South and Central America Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 68. Middle East & Africa Doxorubicin Market Revenue and Forecasts to 2028, By Drug Formulation (US$ Million).
Table 69. Middle East & Africa Doxorubicin Market Revenue and Forecasts to 2028, By Application (US$ Million).
Table 70. Middle East & Africa Doxorubicin Market-Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 71. Saudi Arabia Doxorubicin Market Revenue and Forecasts to 2028, By Drug Formulation (US$ Million).
Table 72. Saudi Arabia Doxorubicin Market Revenue and Forecasts to 2028, By Application (US$ Million).
Table 73. Saudi Arabia Doxorubicin Market-Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 74. South Africa Doxorubicin Market Revenue and Forecasts to 2028, By Drug Formulation (US$ Million).
Table 75. South Africa Doxorubicin Market Revenue and Forecasts to 2028, By Application (US$ Million).
Table 76. South Africa Doxorubicin Market-Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 77. Incidence, Mortality, and Prevalence by cancer site (2020)
Table 78. UAE Doxorubicin Market Revenue and Forecasts to 2028, By Drug Formulation (US$ Million).
Table 79. UAE Doxorubicin Market Revenue and Forecasts to 2028, By Application (US$ Million).
Table 80. UAE Doxorubicin Market-Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 81. Rest Of Middle East & Africa Doxorubicin Market Revenue And Forecasts To 2028, By Drug Formulation (Us$ Million).
Table 82. Rest Of Middle East & Africa Doxorubicin Market Revenue and Forecasts to 2028, By Application (US$ Million).
Table 83. Rest Of Middle East & Africa Doxorubicin Market-Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 84. Organic Developments Done By Companies
Table 85. Inorganic Developments Done by Companies
Table 86. Glossary of Terms, Doxorubicin Market
LIST OF FIGURES
Figure 1. Doxorubicin Market Segmentation
Figure 2. Doxorubicin Market Segmentation, By Region
Figure 3. Global Doxorubicin Market Overview
Figure 4. Lyophilized Powder Segment Held Largest Share by Drug Formulation in Doxorubicin market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Doxorubicin Market, By Geography (US$ Million)
Figure 7. Global Doxorubicin Market - Leading Country Markets (US$ Million)
Figure 8. Global Doxorubicin Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Most Prevalent Forms of Cancers in the World, 2020
Figure 15. Doxorubicin Market Impact Analysis Of Driver And Restraints
Figure 16. Global Doxorubicin Market– Revenue Forecast and Analysis – 2020- 2028
Figure 17. Global Doxorubicin Market– Revenue Forecast and Analysis – 2022- 2028
Figure 18. Global Doxorubicin Market– Market Potential Analysis, By Region
Figure 19. Market Share Analysis of Key Players in Doxorubicin Market
Figure 20. Global Doxorubicin Market– Comparative Company Analysis
Figure 21. Global Doxorubicin Market– Growth Strategy Analysis
Figure 22. Global Doxorubicin Devices Market Share, By Drug Formulation 2022 & 2028 (%)
Figure 23. Lyophilized Powder: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 24. Doxorubicin Injection: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 25. Global Doxorubicin Devices Market Share, By Application 2022 & 2028 (%)
Figure 26. Breast Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 27. Kidney Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 28. Liver Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 29. Sarcoma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 30. Ovarian Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 31. Lung Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 32. Leukemia: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 33. Multiple Myeloma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 34. Others: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 35. Global Doxorubicin Devices Market Share, By Disribution Channel 2022 & 2028 (%)
Figure 36. Hospital Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 37. Retail Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 38. Online Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 39. North America: Doxorubicin Market, By Key Country – Revenue (2022) (US$ Million)
Figure 40. North America Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
Figure 41. North America: Doxorubicin Market, by Country, 2022 & 2028 (%)
Figure 42. US: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Canada: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Mexico: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Europe Doxorubicin Market, Revenue by Country (2022) (US$ Mn)
Figure 46. Europe Doxorubicin Market Revenue and Forecast to 2028 (US$ Mn)
Figure 47. Europe Doxorubicin Market, Revenue and Forecast to 2028, by Country (%)
Figure 48. UK Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)
Figure 49. Germany Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)
Figure 50. France Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)
Figure 51. Italy Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)
Figure 52. Spain Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)
Figure 53. Rest of Europe Doxorubicin Market, Revenue and Forecast to 2028 (US$ Mn)
Figure 54. Asia Pacific Doxorubicin Market, by Key Country – Revenue (2022) (US$ Million)
Figure 55. Asia Pacific Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
Figure 56. Asia Pacific: Doxorubicin Market, by Country, 2022 & 2028 (%)
Figure 57. China: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. Japan: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 59. India: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 60. South Korea: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 61. Australia: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 62. Rest of Asia Pacific: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 63. South and Central America: Doxorubicin Market, By Key Country – Revenue (2022) (US$ Million)
Figure 64. South and Central America Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
Figure 65. South and Central America: Doxorubicin Market, by Country, 2022 & 2028 (%)
Figure 66. Brazil: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 67. Argentina: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 68. Rest of South and Central America: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 69. Middle East & Africa Doxorubicin Market Revenue Overview, by Country, 2022 (US$ Million)
Figure 70. Middle East & Africa Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
Figure 71. Middle East & Africa Doxorubicin Market Revenue and Forecast to 2028, by Country (%)
Figure 72. Saudi Arabia: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
Figure 73. South Africa: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
Figure 74. UAE: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
Figure 75. Rest of Middle East & Africa: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
Figure 76. Impact of COVID-19 Pandemic on North American Country Markets
Figure 77. Impact of COVID-19 Pandemic on European Country Markets
Figure 78. Impact of COVID-19 Pandemic on Asia Pacific Country Markets
Figure 79. Impact of COVID-19 Pandemic on Middle East & Africa Country Markets
Figure 80. Impact of COVID-19 Pandemic on South & Central America Country Markets
Figure 81. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Doxorubicin Market
- Accord Healthcare
- Cipla Inc.
- Dr. Reddy's Laboratories
- Meiji Holdings Co., Ltd.
- Janssen Pharmaceuticals (Johnson and Johnson Services, Inc.)
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Baxter International Inc.
- Zydus Cadila
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Doxorubicin Market
Jul 2022
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jul 2022
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jul 2022
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jul 2022
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jul 2022
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)